Paper8177887
A new method for predicting binding affinity in computer-aided drug design.
Aqvist J and 2 others. Protein Eng, 1994. Cited by 901 papers, by iCite.
Cite this record
ConductScience Library. A new method for predicting binding affinity in computer-aided drug design. Papers, record 8177887. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8177887
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aspartic Acid Endopeptidases | Major topic |
| Computer Simulation | Major topic |
| Drug Design | Major topic |
| Protein Binding | Major topic |
| Binding Sites | |
| Electrochemistry | |
| Molecular Structure | |
| Thermodynamics |
Source PubMed
Cited by313
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 901 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42213377 | Rational design of triazole tyrosinase inhibitors via integrated free energy calculations. | Mol Divers | 2026 | https://conductscience.org/library/papers/42213377 | PubMed |
| 42211269 | Free energy simulations on a biomimetic glucose receptor: understanding the selectivity of GluHUT. | Chem Sci | 2026 | https://conductscience.org/library/papers/42211269 | PubMed |
| 42197237 | s_mmpbsa: A Lite and Cross-Platform MM-PBSA Program. | Molecules | 2026 | https://conductscience.org/library/papers/42197237 | PubMed |
| 42077895 | Semi-solid Extrusion 3D Printing of Chitosan/Carbon Nanotube Nanocomposite Films for Microextraction of Pesticides in Water. | ACS Omega | 2026 | https://conductscience.org/library/papers/42077895 | PubMed |
| 41381731 | Somatic hypermutation patterns are shaped by both motif position and sequence grammar. | EMBO J | 2026 | https://conductscience.org/library/papers/41381731 | PubMed |
| 41046322 | Preclinical Evaluation of a Novel Molecule Targeting Nucleoside Homeostasis to Restore Energy Metabolism and Cognitive Function in Alzheimer's Disease. | Pharmacol Res Perspect | 2025 | https://conductscience.org/library/papers/41046322 | PubMed |
| 40867582 | Characterization of Natural Products as Inhibitors of Shikimate Dehydrogenase from Methicillin-Resistant Staphylococcus aureus: Kinetic and Molecular Dynamics Simulations, and Biological Activity Studies. | Biomolecules | 2025 | https://conductscience.org/library/papers/40867582 | PubMed |
| 40677241 | Predicting receptor-ligand pairing preferences in plant-microbe interfaces via molecular dynamics and machine learning. | Comput Struct Biotechnol J | 2025 | https://conductscience.org/library/papers/40677241 | PubMed |
| 40321554 | Computational Estimation of Residence Time on Roniciclib and Its Derivatives against CDK2: Extending the Use of Classical and Enhanced Molecular Dynamics Simulations. | ACS Omega | 2025 | https://conductscience.org/library/papers/40321554 | PubMed |
| 40202178 | Computation of Protein-Ligand Binding Free Energies with a Quantum Mechanics-Based Mining Minima Algorithm. | J Chem Theory Comput | 2025 | https://conductscience.org/library/papers/40202178 | PubMed |
| 40161316 | Precision spatiotemporal analysis of large-scale compound-protein interactions through molecular dynamics simulation. | PNAS Nexus | 2025 | https://conductscience.org/library/papers/40161316 | PubMed |
| 40123340 | Multisite λ-Dynamics for Protein-DNA Binding Affinity Prediction. | J Chem Theory Comput | 2025 | https://conductscience.org/library/papers/40123340 | PubMed |
| 39951479 | The Need for Continuing Blinded Pose- and Activity Prediction Benchmarks. | J Chem Inf Model | 2025 | https://conductscience.org/library/papers/39951479 | PubMed |
| 39902686 | Potential distribution theory of alchemical transfer. | J Chem Phys | 2025 | https://conductscience.org/library/papers/39902686 | PubMed |
| 39807312 | Discovery of highly potent phosphodiesterase-1 inhibitors by a combined-structure free energy perturbation approach. | Acta Pharm Sin B | 2024 | https://conductscience.org/library/papers/39807312 | PubMed |
| 39804153 | Ligand Reorganization for End-Point Binding Free Energy Calculations: Identifying Preferred Poses of Fentanyls in the μ Opioid Receptor. | J Chem Theory Comput | 2025 | https://conductscience.org/library/papers/39804153 | PubMed |
| 39598537 | Computational Analysis of S1PR1 SNPs Reveals Drug Binding Modes Relevant to Multiple Sclerosis Treatment. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/39598537 | PubMed |
| 39457072 | The Interaction Mechanism Between C14-Polyacetylene Compounds and the Rat TRPA1 Receptor: An In Silico Study. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39457072 | PubMed |
| 39359466 | Searching for potential acetylcholinesterase inhibitors: a combined approach of multi-step similarity search, machine learning and molecular dynamics simulations. | R Soc Open Sci | 2024 | https://conductscience.org/library/papers/39359466 | PubMed |
| 39281668 | Rigid crosslinking of the CD3 complex leads to superior T cell stimulation. | Front Immunol | 2024 | https://conductscience.org/library/papers/39281668 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8177887
GET https://conductscience.org/api/papers/v1/8177887/cited_by?page=2